Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-06-30

Study Completion Date

2007-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Is it possible to decrease the intrarenal pressure in the kidney during endoscopic management of kidney stone by topical administration of drugs? In order to secure fewer complications in ureteroscopic operations the pharmacological agent isoproterenol is tested on pigs and human to determine its potential of lowering intrarenal pressure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Stone Ureteroscopy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Kidney stone ureteropyeloscopy renal pelvic pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Isoproterenol

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indication for RIRS procedure
* Age \> 18 years
* Normotensive
* Capable of understanding information given

Exclusion Criteria

* Previous myocardiac infarct
* Daily use of alpha- og beta- blocking medicine og calcium antagonists
* Use of NSAID the last 2 days
* Stone in the ureter
* Declared
* Known malignant disease in urinary tract
* Bladder disease
* Nephrostomies inserted
* JJ-catheters inserted
* Prisoners
* Pregnant
* Nursing mothers

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Helene U Jung

Role: PRINCIPAL_INVESTIGATOR

Fredericia Hospital, Dpt. of Urology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dpt. of Urology

Fredericia, Vejle Council, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2005-005972-34

Identifier Type: -

Identifier Source: org_study_id